OFFICE OF INSPECTOR GENERAL
Department of Homeland Security
Background
On March 11, 2020, the World Health Organization declared the coronavirus
disease 2019 (COVID-19) a pandemic due to the rapid spread and severity of
the disease. The Centers for Disease Control and Prevention (CDC)
collaborated with other Federal agencies to develop and implement a national
vaccination program, with the interim version “playbook” issued on October 29,
2020.
1
This playbook established recommendations for determining population
groups for initial COVID-19 vaccination distribution. Recommendations
included placing health care personnel in vaccination priority group 1a, and
placing non-health care, frontline, essential workers, such as those in law
enforcement and national security roles, in priority group 1b. On December
11, 2020, the U.S. Food and Drug Administration (FDA) approved the use of
the first COVID-19 vaccine (the vaccine), manufactured by Pfizer BioNTech,
through its Emergency Use Authorization (EUA) authority,
2
with subsequent
EUA approvals issued on December 18, 2020, and February 27, 2021, for the
vaccine from two additional manufacturers.
Department of Homeland Security headquarters and some of its components
employ first responder health care personnel and frontline essential workers,
including those responsible for law enforcement and national security
missions. For example, United States Coast Guard Office of Health Services
and U.S. Immigration and Customs Enforcement (ICE) Health Service Corps
employ health care personnel such as nurses and doctors, and U.S. Customs
and Border Protection (CBP) and United States Secret Service employ frontline
essential employees in the law enforcement field such as Border Patrol agents
and special agents. Prior to the EUA, while the vaccine was still under
development, DHS anticipated the need to coordinate vaccinations for some
employees. To prepare for vaccinating these employees against COVID-19,
DHS asked its components to use the CDC recommendations to determine
which employees to place in priority groups 1a and 1b.
DHS did not directly receive an allocation of vaccine inventory for its
employees. DHS partnered with the Veterans Health Administration (VHA),
which has an established healthcare infrastructure, to make the vaccine
available to DHS personnel in priority groups 1a and 1b. On December 18,
2020, citing DHS’ mission of securing the Homeland, DHS and VHA entered a
memorandum of understanding (MOU) to offer the vaccine to eligible DHS
1
Centers for Disease Control and Prevention, COVID-19 Vaccination Program Interim
Operational Guidance Jurisdiction Operations, Version 2.0, Oct. 29, 2020.
2
During public health emergencies, the FDA can use its EUA authority to allow the use of
unapproved medical products, or unapproved uses of approved medical products, to diagnose,
treat, or prevent serious or life-threatening diseases when certain criteria are met, including
that there are no adequate, approved, and available alternatives.
www.oig.dhs.gov 3 OIG-22-42